Literature DB >> 14676151

Predictors of remission in juvenile-onset recurrent respiratory papillomatosis.

Snehal Ruparelia1, Elizabeth R Unger, Rosane Nisenbaum, Craig S Derkay, William C Reeves.   

Abstract

OBJECTIVE: To determine factors associated with remission of juvenile-onset recurrent respiratory papillomatosis (JORRP).
DESIGN: Longitudinal study.
SETTING: Twenty-two tertiary care centers located across the United States. STUDY PARTICIPANTS AND METHODS: The study included 165 patients diagnosed as having JORRP between January 1, 1997, and December 31, 2000. Kaplan-Meier curves and Cox proportional hazards models were used to determine associations between predictors and remission.
INTERVENTIONS: Surgical excision and drug therapy. MAIN OUTCOME MEASURES: Remission of JORRP, defined as no surgical procedures for at least 1 year, as associated with age at diagnosis, drug therapy in the first year after diagnosis, number of surgical procedures in the first year after diagnosis, and number of anatomical sites of disease at diagnosis. Demographic factors (sex and race) and Medicaid status were also evaluated.
RESULTS: Older age at diagnosis was positively associated with remission of JORRP (hazards ratio for every increase of 1 year in age, 1.13; 95% confidence interval, 1.03-1.23).
CONCLUSIONS: Younger children were found to have persistent disease and often underwent an increased number of surgical procedures in the first year after diagnosis of JORRP. Sex and race were not important factors in determining remission.

Entities:  

Mesh:

Year:  2003        PMID: 14676151     DOI: 10.1001/archotol.129.12.1275

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis.

Authors:  Scott B Drutman; Filomeen Haerynck; Franklin L Zhong; David Hum; Nicholas J Hernandez; Serkan Belkaya; Franck Rapaport; Sarah Jill de Jong; David Creytens; Simon J Tavernier; Katrien Bonte; Sofie De Schepper; Jutte van der Werff Ten Bosch; Lazaro Lorenzo-Diaz; Andy Wullaert; Xavier Bossuyt; Gérard Orth; Vincent R Bonagura; Vivien Béziat; Laurent Abel; Emmanuelle Jouanguy; Bruno Reversade; Jean-Laurent Casanova
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

2.  In RRP, serologic response to HPV is frequently absent and slow to develop.

Authors:  Farrel J Buchinsky; Nicole Ruszkay; William Valentino; Craig S Derkay; John E McClay; Robert W Bastian; Charles M Myer; Kevin W Lollar; Dalya Guris
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

3.  Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States.

Authors:  Elissa Meites; Laura Stone; Raiza Amiling; Vidisha Singh; Elizabeth R Unger; Craig S Derkay; Lauri E Markowitz
Journal:  Clin Infect Dis       Date:  2021-09-07       Impact factor: 20.999

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.